What response rate did NCT00046527 report for Abraxane (albumin-bound paclitaxel)?
I can’t give a specific “response rate” number for NCT00046527 from the information provided in this chat. “NCT00046527” is a clinical trial identifier, and the exact response rate depends on what disease setting and endpoint the trial reported (for example, objective response rate by RECIST, by investigator assessment, and the specific patient population treated with Abraxane).
If you paste the trial’s “Results” (or tell me the cancer type/phase and the endpoint shown in the record), I can extract the precise response rate and report it accurately.
How to find the Abraxane response rate inside the trial record
On ClinicalTrials.gov, the response rate is usually listed under:
- “Outcome Measures” → an endpoint such as “Objective Response Rate (ORR)”
- “Results” → the table for that endpoint, often including a percentage and confidence interval
- Sometimes multiple response rates appear (e.g., for different assessment criteria, lines of therapy, or cohorts)
If you share what the trial lists as the endpoint name (for example, ORR) and the population (phase, indication), I’ll match that to the correct reported number.
What “response rate” might mean for this study
In cancer trials, response rate can vary by:
- Measurement standard (RECIST vs other)
- Whether it includes complete + partial responses
- Whether responses are confirmed
- Whether the trial is randomized (and response rate differs by arm)
If you tell me the trial’s indication or the arm name that corresponds to Abraxane, I’ll help interpret which response rate is the one you likely mean.
If you want, I can also check patent/market context
If your goal is broader than the clinical result (for example, timing of exclusivity around Abraxane), DrugPatentWatch.com can be a helpful reference, but it won’t replace the need to pull the exact response-rate value from the NCT record itself.
Send the ClinicalTrials.gov “Results” snippet (or the endpoint table) for NCT00046527, and I’ll return the exact Abraxane response rate the trial reported.